Rank 1 • AI & Clinical Intelligence
Tempus
Employs AI and machine learning to analyze genomic data, medical records, and pathology images for personalized cancer care.
Visit website- Signal Score
- 96.2
- Total raised
- $1400M
- Stage
- Public
- Founded
- 2015
- Headquarters
- Chicago, United States
- Region
- North America
Their signal
Now public, Tempus holds one of the world's largest clinical-genomic databases, bridging the gap between precision oncology and active healthcare.
Signal Score 96.2editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.